ESTIMATION OF PULMONARY ARTERIAL HYPERTENSION ON PRODUCTIVITY LOSSES IN THE UNITED STATES
Author(s)
Joish VN, Kreilick C, Germino R, Muccino D
Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA
Presentation Documents
OBJECTIVES: Little is known on how pulmonary arterial hypertension (PAH) may impact worker productivity. The objective of this study was to estimate indirect costs of PAH in an employed population. METHODS: Data came from Truven’s MarketScan Health and Productivity Management database. PAH workers were identified based on having >2 medical claims for primary pulmonary hypertension (ICD-9 code:416.0), and either one claim for right heart catheterization or one claim of echocardiogram. The first medical claim during this period served as in the index date with 6 months prior to this event as baseline and 12 months post as follow-up period. Three non-PAH employees were matched to each PAH worker on age, gender, census region, and plan type. Annual productivity loss was calculated as a sum of absenteeism and short term disability (STD) in the follow-up year and derived by multiplying the reported days off work times the industry-specific average daily wage rate obtained from the 2012 US Department of Labor. RESULTS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV95
Topic
Economic Evaluation
Topic Subcategory
Work & Home Productivity - Indirect Costs
Disease
Cardiovascular Disorders